MN SF1912

Requires the prescribing physician to be physically present in the same room when RU-486 (mifepristone) or any other abortion-inducing drug or chemical is administered to a patient.

Mandates that the physician or their representative make all reasonable efforts to schedule a follow-up visit 12 to 18 days after drug administration to confirm pregnancy termination and assess the patient's medical condition.

Requires documentation in the patient's medical record of follow-up efforts, including the date, time, and name of the person making such efforts.

Defines "abortion" as the use of any instrument, medicine, drug, or substance to terminate a known pregnancy, with exceptions for procedures to preserve the life or health of the child, preserve the mother's health, or remove a naturally deceased fetus.

Applies to violations of these requirements, establishing that attempts to perform or induce an abortion contrary to these provisions constitute statutory violations.